Ro (formerly Roman)

Ro is a direct-to-consumer telehealth company, meaning a patient connects with a licensed clinician online, gets a diagnosis and a prescription when appropriate, and receives the medication by mail — no waiting room, no separate pharmacy trip. It launched in 2017 as Roman, a brand built narrowly around erectile dysfunction and men's sexual health, a category people were often too embarrassed to raise with a doctor in person. That single, stigmatized problem was the wedge. As the company added hair loss, weight management, mental health, skincare, and general primary-care services, the tight Roman name no longer fit, so the parent brand became Ro, with Roman surviving as one of its condition-specific storefronts. Behind the marketing sit in-house pharmacies and a mail-order operation that let Ro control fulfillment rather than hand it off.

The company's structure is worth understanding because it shapes the brand. Ro is the umbrella; Roman, Rory (women's health), and other lines are the front doors for specific needs, and the pharmacy plus clinician network is the shared engine. Revenue comes largely from recurring subscriptions to treatments, which is why acquisition and retention economics drive the business the way they drive any subscription brand. For a marketer, Ro is a clean case of a company that used one embarrassing, high-intent problem to earn a direct relationship with a customer, then expanded the catalog against that relationship — a playbook of wedge, trust, and cross-sell rather than a broad launch that tries to be everything at once.

The obvious cousin is Hims & Hers, and the two are genuinely close: both are DTC telehealth brands that started in men's health, both sell recurring treatments for stigmatized conditions online, and both expanded into women's health, weight, and skin. The differences are in emphasis and structure. Ro leaned early and hard into owning pharmacy and fulfillment in-house, framing itself as a full patient-care company with its own dispensing operation. Hims & Hers went public and built an unusually loud consumer brand, with heavy performance marketing and a strong retail-and-app presence, positioning itself as a broad wellness platform. Both chase the same customer, so on any given condition they compete head-to-head.

Naming the contrast matters because it is easy to treat these brands as interchangeable, and they are not. If you study Ro, you are studying a company that emphasizes clinical infrastructure and pharmacy control; if you study Hims & Hers, you are studying a publicly traded brand machine with enormous marketing scale and a wide personal-care catalog. Both illustrate the same DTC-telehealth thesis — win a private, high-intent health problem online, then expand the relationship — but they express it differently. For competitive analysis, the useful move is to hold the shared model constant and read each brand's distinct bet on infrastructure, marketing, and category breadth against it.

Ro is instructive as a direct-to-consumer model built on trust in a low-trust category. The lessons transfer beyond healthcare. Start with a specific, high-intent problem people struggle to solve elsewhere; make the experience private, fast, and low-friction; own enough of the fulfillment chain to control quality and margin; then expand the catalog only against a relationship you have already earned. The subscription economics mean lifetime value and retention decide whether the acquisition spend pays back, so the brand lives or dies on whether patients stay, not just whether they sign up. Ro's move from Roman to a broad umbrella shows the upside of that patience — and the naming challenge of a brand that outgrows its origin.

The traps are the ones every regulated DTC brand faces. In healthcare, aggressive marketing collides with clinical responsibility, so a telehealth company that pushes convenience too hard risks trust, outcomes, and regulatory scrutiny all at once. Expanding the catalog before the core relationship is solid dilutes the brand instead of leveraging it. And leaning on a stigmatized wedge for growth means messaging must stay respectful and evidence-based, not exploitative. The discipline is to treat Ro not as a marketing story alone but as a clinical service wearing a strong consumer brand — the parts have to stay in balance, or the convenience that won the customer becomes the thing that loses their trust.

Ro, launched as Roman in 2017, is a direct-to-consumer telehealth and pharmacy company that began in men's sexual health and rebranded as it expanded into broad online care.

Etymology: source.

Search interest for this term over the last five years:

View interest-over-time on Google Trends →

Areas of marketing where ro (formerly roman) is a core concern: